Scientific Regulatory Policy Committee Points to Consider*: Nuisance Factors, Block Effects, and Batch Effects in Nonclinical Safety Assessment Studies

Author:

Schultze Albert Eric1ORCID,Bennet Bindu2,Rae Jessica Caverly3,Chiang Alan Y.4,Frazier Kendall3ORCID,Katavolos Paula5,McKinney LuAnn6,Patrick Daniel J.7ORCID,Tripathi Niraj8

Affiliation:

1. Eli Lilly and Company, Indianapolis, IN, USA

2. Janssen Pharmaceuticals, Spring House, PA, USA

3. GlaxoSmithKline, King of Prussia, PA, USA

4. Celgene, Summit, NJ, USA

5. Genentech, South San Francisco, CA, USA

6. US Food and Drug Administration, Silver Spring, MD, USA

7. Charles River Laboratories, Mattawan, MI, USA

8. Covance Laboratories, Madison, WI, USA

Abstract

Detection of test article–related effects and the determination of the adversity of those changes are the primary goals of nonclinical safety assessment studies for drugs and chemicals in development. During these studies, variables that are not of primary interest to investigators may change and influence data interpretation. These variables, often referred to as “nuisance factors,” may influence other groups of data and result in “block or batch effects” that complicate data interpretation. Definitions of the terms “nuisance factors,” “block effects,” and “batch effects,” as they apply to nonclinical safety assessment studies, are reviewed. Multiple case examples of block and batch effects in safety assessment studies are provided, and the challenges these bring to pathology data interpretation are discussed. Methods to mitigate the occurrence of block and batch effects in safety assessment studies, including statistical blocking and utilization of study designs that minimize potential confounding variables, incorporation of adequate randomization, and use of an appropriate number of animals or repeated measurement of specific parameters for increased precision, are reviewed. [Box: see text]

Publisher

SAGE Publications

Subject

Cell Biology,Toxicology,Molecular Biology,Pathology and Forensic Medicine

Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3